These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26409831)

  • 21. Association between bone marrow dosimetric parameters and acute hematologic toxicity in cervical cancer patients undergoing concurrent chemoradiotherapy: comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy.
    Hui B; Zhang Y; Shi F; Wang J; Wang T; Wang J; Yuan W; Li Y; Liu Z
    Int J Gynecol Cancer; 2014 Nov; 24(9):1648-52. PubMed ID: 25275663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial Results from the Royal College of Radiologists' UK National Audit of Anal Cancer Radiotherapy 2015.
    Muirhead R; Drinkwater K; O'Cathail SM; Adams R; Glynne-Jones R; Harrison M; Hawkins MA; Sebag-Montefiore D; Gilbert DC
    Clin Oncol (R Coll Radiol); 2017 Mar; 29(3):188-197. PubMed ID: 27810119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison and limitations of DVH-based NTCP models derived from 3D-CRT and IMRT data for prediction of gastrointestinal toxicities in prostate cancer patients by using propensity score matched pair analysis.
    Troeller A; Yan D; Marina O; Schulze D; Alber M; Parodi K; Belka C; Söhn M
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):435-43. PubMed ID: 25636766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose to Pelvic Bone Marrow Defined with FDG-PET Predicts for Hematologic Nadirs in Anal Cancer Patients Treated with Concurrent Chemo-radiation.
    Franco P; Arcadipane F; Ragona R; Lesca A; Gallio E; Mistrangelo M; Trino E; Cassoni P; Arena V; Baccega M; Racca P; Faletti R; Rondi N; Morino M; Ricardi U
    Cancer Invest; 2018; 36(5):279-288. PubMed ID: 29953269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and dosimetric predictors of acute hematologic toxicity in rectal cancer patients undergoing chemoradiotherapy.
    Yang TJ; Oh JH; Apte A; Son CH; Deasy JO; Goodman KA
    Radiother Oncol; 2014 Oct; 113(1):29-34. PubMed ID: 25304718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved treatment outcome and lower skin toxicity with intensity-modulated radiotherapy vs. 3D conventional radiotherapy in anal cancer.
    Sauter M; Lombriser N; Bütikofer S; Keilholz G; Kranzbühler H; Heinrich H; Rogler G; Vavricka SR; Misselwitz B
    Strahlenther Onkol; 2020 Apr; 196(4):356-367. PubMed ID: 31980834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?
    Wan J; Liu K; Li K; Li G; Zhang Z
    Radiat Oncol; 2015 Aug; 10():162. PubMed ID: 26238572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy.
    Wijsman R; Dankers F; Troost EG; Hoffmann AL; van der Heijden EH; de Geus-Oei LF; Bussink J
    Radiother Oncol; 2015 Oct; 117(1):49-54. PubMed ID: 26341608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
    Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective dosimetric and clinical comparison of acute hematological toxicities in three-dimensional conformal radiation therapy and intensity modulated radiation therapy with concurrent chemotherapy in carcinoma cervix.
    Avinash HU; Arul Ponni TR; Janaki MG; Kirthi Koushik AS; Kumar SM
    J Cancer Res Ther; 2015; 11(1):83-7. PubMed ID: 25879342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
    Dijkema T; Terhaard CH; Roesink JM; Braam PM; van Gils CH; Moerland MA; Raaijmakers CP
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1101-9. PubMed ID: 18472355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.
    Goenka A; Magsanoc JM; Pei X; Schechter M; Kollmeier M; Cox B; Scardino PT; Eastham JA; Zelefsky MJ
    Eur Urol; 2011 Dec; 60(6):1142-8. PubMed ID: 21855208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute toxicity with intensity modulated radiotherapy versus 3-dimensional conformal radiotherapy during preoperative chemoradiation for locally advanced rectal cancer.
    Ng SY; Colborn KL; Cambridge L; Hajj C; Yang TJ; Wu AJ; Goodman KA
    Radiother Oncol; 2016 Nov; 121(2):252-257. PubMed ID: 27751605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer.
    Shaikh T; Wang LS; Egleston B; Burki M; Hoffman JP; Cohen SJ; Meyer JE
    Am J Clin Oncol; 2018 Jan; 41(1):59-64. PubMed ID: 26325492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of bone marrow irradiation dose on acute haematologic toxicity in cervical cancer patients treated with concurrent chemoradiotherapy.
    Chen M; Wang D; Bao Z; Yi Z; Mei Z; Sun S; Xiang Q; Yang C; Yang H; Qiu H; Xie C
    Radiat Oncol; 2023 Apr; 18(1):66. PubMed ID: 37031167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
    Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies.
    Brixey CJ; Roeske JC; Lujan AE; Yamada SD; Rotmensch J; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1388-96. PubMed ID: 12459361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small bowel toxicity in pelvic radiotherapy for postoperative gynecological cancer: comparison between conformal radiotherapy and intensity modulated radiotherapy.
    Ray A; Sarkar B
    Asia Pac J Clin Oncol; 2013 Sep; 9(3):280-4. PubMed ID: 23279854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients.
    Wortel RC; Incrocci L; Pos FJ; Lebesque JV; Witte MG; van der Heide UA; van Herk M; Heemsbergen WD
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):737-44. PubMed ID: 25752386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematologic Toxicity Comparison of Intensity Modulated Proton Therapy and Intensity Modulated Radiation Therapy in Anal Cancer Patients.
    Nelson B; Tadesse DG; Sudhoff M; Wang K; Meier T; Mascia A; Kharofa J
    Am J Clin Oncol; 2022 Jun; 45(6):264-267. PubMed ID: 35588226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.